| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $96.7M | -0.0% |
| SG&A Expense | $31.4M | -9.8% |
| Operating Income | -$128.2M | +2.6% |
| Income Tax | $0 | — |
| Net Income | -$108.8M | +7.4% |
| EPS (Basic) | -$1.60 | +33.3% |
| EPS (Diluted) | -$1.60 | +33.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.9M | -10.2% |
| Short-term Investments | $239.5M | +10.3% |
| Current Assets | $273.3M | +8.0% |
| Total Assets | $501.2M | +32.3% |
| Current Liabilities | $18.9M | -18.9% |
| Total Liabilities | $93.2M | -11.7% |
| Stockholders' Equity | $408.0M | +49.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$99.7M | -15.7% |
| Capital Expenditures | $4.4M | -84.3% |
| Investing Cash Flow | -$129.6M | -264.0% |
| Financing Cash Flow | $226.1M | — |
| Free Cash Flow | -$104.1M | +8.9% |